Comparison of Five Different Methods for Detection of SHV Extended-Spectrum β-Lactamases

REFERENCES

• Philippon A, Labia R, Jacoby G. Extended- spectrum - lactamases. Antimicrob Agents Chemother 1989; 33: 1131–6.
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Medeiros AA. More extended-spectrum -lac-tamases. Antimicrob Agents Chemother 1991; 35 (9): 1697–704.
   PubMed Web of Science ®Google Scholar
• Philippon A, Arlet G, Langrange PH. Origin and impact of plasmid-mediated extended-spectrum I3-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13 (suppl 13): 17-29.
   Google Scholar
• Jacoby GA. Genetics of extended-spectrum I3-lacta-mases. Eur J Clin Microbiol Infect Dis 1994; 13 (supp1.1): 2-11.
   Google Scholar
• Ambler RP, Coulson FW, Frere JM, et al. A standard numbering scheme for the class A I3-lactamases. Biochem J 1991; 276: 269–72.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum I3-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409–24.
   PubMed Web of Science ®Google Scholar
• Coudron PE, Moland ES, Sanders CC. Occurrence and detection of Extended-spectrum I3-lactamases in members of the family Enterobacteriaceae at a Veterans Medical Center: Seek and you may find. J Clin Microbiol 1997; 35: 2593–7.
   PubMed Web of Science ®Google Scholar
• French GL, Shannon KP, Simmons N. Hospital out-break of Klebsiella pneumoniae resistant to broad spectrum cephalosporins and I3-lactam—I3-lactamase inhibitor combina-tions by hyperproduction of SHV-5 I3-lactamase. J Clin Microbiol 1996, 34 (2): 358–363.
   PubMed Web of Science ®Google Scholar
• Petit A, Sirot DL, Chanal CM, et al. Novel plasmid mediated -lactamase in clinical isolates of Klebsiella pneumo-niae more resistant to ceftazidime than to other broad-spec-trum cephalosporins. Antimicrob Agents Chemother 1988; 32 (5): 626–30.
   PubMed Web of Science ®Google Scholar
• Venezia R, Scarano FJ, Preston KE, et al. Molecular epidemiology of an SHV-5 extended-spectrum I3-lactamase in a neonatal intensive care unit. Clin Infect Dis 1995; 21: 915–23.
   PubMed Web of Science ®Google Scholar
• Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type I3-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia colt in Greece. J Antimicrob Chemother 1990; 26: 635–48.
   PubMed Web of Science ®Google Scholar
• Gniadkowski M, Schneider I, Jungwirth R, Hryniewicz V, Bauernfeind A. Ceftazidime-resistant Enterobacteriaceaea isolates from three polish hospitals: identification of three novel TEM-extended-spectrum -lactamases. Antimicrob Agents Chemother 1998; 42: 514–20.
   PubMed Web of Science ®Google Scholar
• Prodinger WM, Fille M, Bauernfeind A, et al. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 13-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996; 34 (3): 564–8.
   PubMed Web of Science ®Google Scholar
• Nuesch-Inderbinen MT, Kayser FH, Haechler H. Survey and molecular genetics of SHV I3-lactamases in Enterobacteriaceae in Switzerland: Two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother 1997; 41 (5): 943–949.
   PubMed Web of Science ®Google Scholar
• Bedenic B, Zagar Z. Extended-spectrum I3-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia. J Chemother 1998 10 (6): 449–459.
   PubMed Web of Science ®Google Scholar
• Bedenic B, Randegger C, Haechler H, Stobberingh EE. Unpublished results.
   Google Scholar
• Bradford PA, Urban C, Jaiswal A, et al. SHV-7, a novel cefotaxime-hydrolyzing I3-lactamase, identified in Escherichia colt isolates from hospitalized nursing home patients. Antimicrob Agents Chemother 1995; 39 (4): 899–905.
   PubMed Web of Science ®Google Scholar
• Thomson KS, Sanders CC. Detection of extended-spec-trum I3-lactamases in the members of the familiy Enterobacteriaceae— comparison of the double-disc and 3-dimensional tests. Antimicrob Agents Chemother 1992; 36: 1877-82.
   Google Scholar
• Elwell LP, Falkow S. The characterization of R plas-mids and the detection of plasmid-specified genes. In: Antibiotics in Laboratory Medicine, 2nd edn (Lorian V Ed), Baltimore, MD: Williams and Wilkins, 1986: 683-721.
   Google Scholar
• Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum I3-lactamases conferring transferable resistance to newer I3-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867–78.
   PubMedGoogle Scholar
• Ho PL, Chow KH, Yuen KY, Ng WS, Chau PY. Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum 13-lactamases in Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 1998; 42: 49–54.
   PubMed Web of Science ®Google Scholar
• Jones RN, Barry AA, Gavan TL, Washington JA. Susceptibility tests: microdilution and macrodilution broth procedures. In: Manual of Clinical Microbiology, 4th edn (Lennette EH Ed), Washington DC: American Society for Microbiology, 1985: 972-7.
   Google Scholar
• Vercauteren E, Desheemaeker P, Ieven M, Sanders CC, Goossens H. Comparison of screening methods for detection of extended-spectrum I3-lactamases and their preva-lence among blood isolates of Escherichia cob and Klebsiella spp. in a Belgian Teaching Hospital. J Clin Microbiol 1997; 35 (9): 2191–7.
   PubMed Web of Science ®Google Scholar
• Neusch-Inderbinen M, Haechler H, Kayser FH. Detection of extended-spectrum SHV I3-lactamases in clinical isolates by a precise genetic method and comparison with E test. Eur J Clin Infect Dis 1996; 15: 398–402.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Williams JD. I3-lactams: mode of action and mechanisms of bacterial resistance. In: Antibiotics in Laboratory Medicine, 4th edn (Lorian V Ed.), Baltimore, MD: Williams & Wilkins, 1996: 502-78.
   Google Scholar